Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2021 Results Report

Rhea-AI Summary

Progyny, Inc. (Nasdaq: PGNY) will announce its financial results for the quarterly period and full year ending December 31, 2021, on February 28, 2022. A conference call will be held at 4:45 PM ET to discuss the results, with access details provided for U.S. and international participants. An audio replay will be available until March 7, 2022. Progyny specializes in fertility and family building benefits, focusing on education and access to specialists while reducing costs for employers. The company has received recognition for its growth and leadership in the sector.

Positive

• The company is set to release important financial results on February 28, 2022.
• Progyny is recognized for its leadership and growth in the fertility benefits management sector.

Negative

• None.

NEW YORK, Feb. 11, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period and full year ended December 31, 2021 after the close of the market on Monday, February 28, 2022.

The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call.

Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode.

An audio replay of the call will be available through Monday, March 7, 2022 and may be accessed by dialing 1.800.332.6854 (U.S. participants) or 1.973.528.0005 (international participants) with the passcode 265484.

A live webcast and archive of the call will be available from the Events and Presentations section of the Company’s website at http://investors.progyny.com.

About Progyny
Progyny (Nasdaq: PGNY) is a leading fertility benefits management company in the US. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians. 

Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.

Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.

For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com

Media:
Selena Yang
media@progyny.com

FAQ

When will Progyny report its financial results for 2021?

Progyny will report its financial results for the quarterly period and full year ended December 31, 2021, on February 28, 2022.

What time is the conference call for Progyny's financial results?

The conference call will take place at 4:45 PM Eastern Time.

How can I access the Progyny conference call?

Participants in the U.S. can access the call by dialing 1.866.825.7331 and using the passcode 265484.

Is there a replay available for Progyny's conference call?

Yes, an audio replay will be available until March 7, 2022.

What is Progyny's focus in the market?

Progyny specializes in fertility and family building benefits, providing comprehensive solutions to employers and patients.